WO2025188755 - ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
National phase entry is expected:
Publication Number
WO/2025/188755
Publication Date
11.09.2025
International Application No.
PCT/US2025/018343
International Filing Date
04.03.2025
Title **
[English]
ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
[French]
COMPOSITIONS DE VIRUS ADÉNO-ASSOCIÉS POUR LE TRAITEMENT DE LA DYSTROPHIE MUSCULAIRE DE DUCHENNE
Applicants **
KATE THERAPEUTICS, INC.
Inventors
MONAVARFESHANI, Aboozar
SESHADRI, Saurav
TABEBORDBAR, Mohammadsharif
TABEBORDBAR, Shayan
VELEZ, Danielle
YE, Simon
Priority Data
65/561,130
04.03.2024
US
63/666,899
02.07.2024
US
63/676,780
29.07.2024
US
63/688,024
28.08.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 7477 | |
| EPO | Filing, Examination, Granting | 65349 | |
| Japan | Filing, Examination, Granting | 3949 | |
| South Korea | Filing, Examination, Granting | 5668 | |
| USA | Filing, Examination, Granting | 21290 |
Total:
103,733
Contact Us
Abstract[English]
The present invention provides novel gene therapy compositions for use in treatment of Duchenne Muscular Dystrophy (DMD).[French]
La présente invention concerne de nouvelles compositions de thérapie génique destinées à être utilisées dans le traitement de la dystrophie musculaire de Duchenne (DMD).